All CoverageAdverse Events & ComorbiditiesJournal Articles Disagree on ART-Related Weight GainBarbara JungwirthNews3 Min ReadA new study measured body weight changes after HIV antiretroviral therapy initiation to determine the effect of specific HIV drugs and classes. But study authors and commenting physicians disagreed on the findings. Adverse Events & ComorbiditiesJournal Articles Disagree on ART-Related Weight GainBarbara JungwirthNews3 Min ReadA new study measured body weight changes after HIV antiretroviral therapy initiation to determine the effect of specific HIV drugs and classes. But study authors and commenting physicians disagreed on the findings. Providing Quality HIV CareHIV Outcomes Differ Little by Provider Type in U.S.Barbara JungwirthNews3 Min ReadU.S. survey data suggest that comprehensive HIV care can improve if it is led by infectious disease physicians while also integrating primary care providers in ID practices. Providing Quality HIV CareHIV Outcomes Differ Little by Provider Type in U.S.Barbara JungwirthNews3 Min ReadU.S. survey data suggest that comprehensive HIV care can improve if it is led by infectious disease physicians while also integrating primary care providers in ID practices. Adverse Events & ComorbiditiesStudy Bite: ART Reduces Some Cancer Risks Among PLWHBarbara JungwirthNews2 Min ReadUsing HIV and cancer registries and linking to a prescription claims database, a real-world study in Texas looked at associations between the use of antiretroviral therapy and the risk for developing various cancers. Adverse Events & ComorbiditiesStudy Bite: ART Reduces Some Cancer Risks Among PLWHBarbara JungwirthNews2 Min ReadUsing HIV and cancer registries and linking to a prescription claims database, a real-world study in Texas looked at associations between the use of antiretroviral therapy and the risk for developing various cancers. Managing People Newly Diagnosed With HIVStudy Bite: Global Review Reports High Prevalence of Delayed ARTBarbara JungwirthNews2 Min ReadA large, global meta-analysis found that many people diagnosed with HIV still delay starting treatment by at least 30 days—even when they have a CD4 count at or below 200. Managing People Newly Diagnosed With HIVStudy Bite: Global Review Reports High Prevalence of Delayed ARTBarbara JungwirthNews2 Min ReadA large, global meta-analysis found that many people diagnosed with HIV still delay starting treatment by at least 30 days—even when they have a CD4 count at or below 200. HIV Care ContinuumThis Week in HIV Research: Left BehindBarbara Jungwirth; Myles HelfandNews1 Min ReadDec. 9, 2021: HIV care continuum trends; few social determinants of health in treatment intervention studies; keys to diabetes control; the role of HIV in diabetes risk. HIV Care ContinuumThis Week in HIV Research: Left BehindBarbara Jungwirth; Myles HelfandNews1 Min ReadDec. 9, 2021: HIV care continuum trends; few social determinants of health in treatment intervention studies; keys to diabetes control; the role of HIV in diabetes risk. HIV Treatments in DevelopmentAdvances in Treating HIV: Are Personalized bNAb Cocktails the Way of the Future?Barbara JungwirthNews5 Min ReadA novel HIV therapy may prove most beneficial to people who start ART during the early weeks of infection. HIV Treatments in DevelopmentAdvances in Treating HIV: Are Personalized bNAb Cocktails the Way of the Future?Barbara JungwirthNews5 Min ReadA novel HIV therapy may prove most beneficial to people who start ART during the early weeks of infection. PrEP (HIV Pre-Exposure Prophylaxis)This Week in HIV Research: The Realities of PrEPBarbara Jungwirth; Myles HelfandNews1 Min ReadJune 17, 2021: PrEP awareness vs. PrEP willingness among young Black women; acute HIV infection during PrEP initiation; real-world PrEP efficacy; HIV rates by U.S. region among transgender people. PrEP (HIV Pre-Exposure Prophylaxis)This Week in HIV Research: The Realities of PrEPBarbara Jungwirth; Myles HelfandNews1 Min ReadJune 17, 2021: PrEP awareness vs. PrEP willingness among young Black women; acute HIV infection during PrEP initiation; real-world PrEP efficacy; HIV rates by U.S. region among transgender people. First-Line HIV TreatmentImmediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSMTerri Wilder, M.S.W.; Myles HelfandQ&A11 Min ReadIntegrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well. First-Line HIV TreatmentImmediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSMTerri Wilder, M.S.W.; Myles HelfandQ&A11 Min ReadIntegrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well. HIV Care ContinuumThis Week in HIV Research: Setting a New BarBarbara Jungwirth; Myles HelfandNews1 Min ReadJune 11, 2020: Diagnosis rates within a year of infection; rates of intentional non-daily PrEP use; neurological development in children of birth parents with HIV; point-of-care urine test to assess tenofovir levels. HIV Care ContinuumThis Week in HIV Research: Setting a New BarBarbara Jungwirth; Myles HelfandNews1 Min ReadJune 11, 2020: Diagnosis rates within a year of infection; rates of intentional non-daily PrEP use; neurological development in children of birth parents with HIV; point-of-care urine test to assess tenofovir levels. Prevention MethodsThis Week in HIV Research: The Fast-Acting Power of IntegraseBarbara Jungwirth; Myles HelfandNews1 Min ReadApril 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services. Prevention MethodsThis Week in HIV Research: The Fast-Acting Power of IntegraseBarbara Jungwirth; Myles HelfandNews1 Min ReadApril 9, 2020: Rapid efficacy of integrase-based treatment; a potent PrEP ad campaign in Chicago; more frequent STI screening for PrEP users; Ryan White funding fuels critical rural HIV care and services. Providing Quality HIV CareCommunities Should Be Involved in Research. Here Are Some Key Insights on Good Participatory Practice.Barbara JungwirthNews5 Min ReadIncreasingly, researchers are looking for ways to involve communities not just by participating in trials, but by helping shape these projects. But, how do you go about making sure affected communities are at the table? Providing Quality HIV CareCommunities Should Be Involved in Research. Here Are Some Key Insights on Good Participatory Practice.Barbara JungwirthNews5 Min ReadIncreasingly, researchers are looking for ways to involve communities not just by participating in trials, but by helping shape these projects. But, how do you go about making sure affected communities are at the table? Providing Quality HIV CareGetting PrEP to People by Training Entire Health TeamsTerri Wilder, M.S.W.News17 Min ReadPrimary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine. Providing Quality HIV CareGetting PrEP to People by Training Entire Health TeamsTerri Wilder, M.S.W.News17 Min ReadPrimary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.
